The 18th International Conference on HIV Treatment and Prevention Adherence was held June 11-13, 2023, in Fajardo, Puerto Rico. Learn more about Adherence 2023 and the exciting work of our CHIPTS scientists featured at the conference below.
What is Adherence 2023?
Adherence 2023 marked the 18th iteration of this engaging conference that supports researchers, practitioners, advocates, and policy makers from around the world to share, support, and sustain scientific advances in improving HIV medication adherence. The conference focuses on leveraging available social-behavioral and biomedical treatments to promote the health and well-being of people affected by and those living with HIV. This year’s conference theme was Advancing Equity and Innovation for Impact. The theme was woven throughout the conference program, which featured a keynote address, memorial lecture/colloquium, four topical tracks (Optimizing ART Adherence; PrEP Uptake, Adherence, and Persistence; HIV Care Continuum; and Implementation Science), oral abstracts sessions (including late-breakers), and an e-poster abstracts session.
The conference’s learning objectives included:
- Employing interventions to enhance linkage to and retention in and sustained engagement in HIV care.
- Applying strategies to optimize antiretroviral therapy and pre-exposure prophylaxis adherence.
- Utilizing implementation science to inform evidence-based approaches to implement optimized HIV responses.
- Integrating community participatory engagement into clinical practice to support patient-focused care environments.
CHIPTS at Adherence 2023
CHIPTS Development Core Co-Director Dr. Dallas Swendeman was featured during the Three Top-Rated Abstracts session on the opening day of Adherence 2023. Dr. Swendeman presented his Adolescent HIV Medicine Trials Network (ATN) randomized controlled trial evaluating the independent and synergistic effects of three “disruptive innovation” intervention approaches to support HIV prevention outcomes among youth at risk for HIV (oral abstract 1278).
CHIPTS Project Director Elena Rosenberg-Carlson presented on Monday, July 12, during the oral abstract session on Implementation Strategies for HIV Treatment and Prevention. Ms. Rosenberg-Carlson’s presentation detailed the methods and key findings from a study led by CHIPTS Combination Prevention Core Scientist Dr. Ronald Brooks that used a concept mapping approach to develop implementation strategies to enhance PrEP delivery to immigrant Latino men who have sex with men in Los Angeles County (oral abstract 1205). Ms. Rosenberg-Carlson also presented a poster on behalf of Dr. Brooks’ study team discussing the preliminary findings from a qualitative study with immigrant Latino men who have sex with men in Los Angeles County that aimed to assess the effects of intersecting socially disadvantaged identities and structural factors on the use of HIV prevention services (poster abstract 1262).
CHIPTS Combination Prevention Core Scientist Dr. Laura Bogart presented a poster at Adherence 2023, as well, describing her successful pilot test of the multi-level adherence intervention “Mopati” for people living with HIV and their treatment partners in Botswana (poster abstract 1047). Her work was also featured as part of the study team presenting poster abstract 1031, which discussed findings from their study to understand the sociodemographic and psychosocial correlates of Black adults living with HIV who are lonely, and the implications of loneliness for their health outcomes.
To learn more about Adherence 2023 and access the conference materials, visit: https://www.iapac.org/conferences/adherence-2023/